Tempest Therpeutics Inc News - TPST

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Form DEF 14A - Other definitive proxy statements

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update

Building upon a successful end-of-Phase 2 meeting, received FDA “Study May Proceed” letter for pivotal Phase 3...

Form 8-K - Current report

Tempest Receives FDA Study May Proceed for Pivotal Phase 3 Trial of Amezalpat Combination Therapy for the Treatment of First-Line Hepatocellular Carcinoma

BRISBANE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a...

Form PRE 14A - Other preliminary proxy statements

Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]

Form 8-K - Current report

Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial

BRISBANE, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a...

Tempest Extends Limited Duration Stockholder Rights Plan

BRISBANE, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest” or...

Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a...

Tempest Further Strengthens Leadership Team with Appointment of Sheldon Mullins as Vice President, Regulatory Affairs

BRISBANE, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a...

Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference

BRISBANE, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a...

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a...

Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance

BRISBANE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a...

georgie18 3 days ago

TPST...$1.09...🥳...BRISBANE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that the company received a “Study May Proceed” letter from the U.S. Food and Drug Administration (FDA) to evaluate amezalpat (TPST-1120) in combination with atezolizumab and bevacizumab, the current standard of care, versus the standard of care alone in a pivotal randomized Phase 3 trial for the first-line treatment of unresectable or metastatic hepatocellular carcinoma (HCC).

“The clinical and regulatory team at Tempest are thrilled to receive this notice from FDA with respect to the planned pivotal Phase 3 trial to evaluate amezalpat as a potential treatment for first-line liver cancer,” said Sam Whiting M.D., Ph.D., chief medical officer and head of R&D of Tempest. “Previously reported positive Phase 2 data underscore amezalpat’s potential to improve the survival of patients facing this life-threatening disease, and our team is dedicated to advancing the program and bringing amezalpat to patients.”

georgie18

Member Level
Re: None

Friday, November 08, 2024 6:22:34 PM

Post#
664322
of 664538
TPST...$1.09...Chart firming up from the .85 Range Bottom...R/S coming here...🥳

👍️0

aBeezlee 5 days ago

I sold my shares, but kept the calls.

👍️0

georgie18 6 days ago

TPST...$1.09...Chart firming up from the .85 Range Bottom...R/S coming here...🥳

👍️0

aBeezlee 1 week ago

Not a bad recovery. Will see if an ER or business report is released, then decide to sell or not.

👍️0

Monksdream 2 weeks ago

TPST , new 52 week low

👍️0

stockyupydowny 2 weeks ago

Agreed, we will see positive news and a boost in price prior to the split..... the higher the price the lower the split IF its even required. Should they get positive news and more support from ROCHE this can rocket and then cancel split... that's moon time!

👍️ 1

georgie18 2 weeks ago

We shall see...🥳

👍️0

aBeezlee 2 weeks ago

1 to 2, or 1 to 15 RS. The split doesn't make sense unless a notable event is coming. Negative sentiment will simply beat it down, and kill existing holders further.

I'm under the impression dilution is coming.

👍️0

georgie18 2 weeks ago

Yes I did...will buy back when the dust settles...🥳...made great profit with TPST and if the reverse should happen it should put this stock in the $40...imo...we shall see...

👍 1

rocketeer357 2 weeks ago

Did you sell on the 14a news?

👍️0

georgie18 2 weeks ago

You saw the 14a...🥳

👍️0

The GidDy uP Kid 2 weeks ago

aDDed after hours sub $1 range...

👍️0

aBeezlee 2 weeks ago

RS was unexpected for something without a delisting notice. Perhaps something planned to prevent a takeover. Hmm...

👍️0

georgie18 2 weeks ago

TPST...14A Filing...Approval of a series of alternate amendments to our Restated Certificate of Incorporation to effect, at the option of our Board of Directors, a reverse stock split of our common stock at a ratio in the range of 1-for-2 to 1-for-15, inclusive, with such ratio to be determined by our Board of Directors in its sole discretion (“Reverse Stock Split Proposal” or “Proposal 1”).
What if another matter is properly brought before the Special Meeting?

👍 1

georgie18 2 weeks ago

TPST....85...A/H Dip...🥳

👍️0

georgie18 2 weeks ago

Nice to have you with me on it...🥳

👍️0

tw0122 2 weeks ago

One of your GM favorites been adding myself low $1s for next blastoff to $2s ...newsand trials

👍️0

georgie18 2 weeks ago

TPST...$1.16s in the P/M...🥳

georgie18

Member Level
Re: georgie18 post# 614

Friday, October 25, 2024 12:38:28 PM

Post#
615
of 617
TPST...$1.12s clearing here...🥳Reversing...

georgie18

Member Level
Re: georgie18 post# 662364

Friday, October 25, 2024 9:43:40 AM

Post#
662715
of 662771
TPST...$1.08...Big Block Buys hitting here...🥳

georgie18

Member Level
Re: None

Wednesday, October 23, 2024 8:55:30 AM

Post#
613
of 613
TPST...Loaded $1.03 to $1.05s...🥳

👍️0

aBeezlee 3 weeks ago

Long hold. Roche wouldn't supply them with goods if they felt phase 3 would fail. Looking for $2 on positive results.

👍️0

georgie18 3 weeks ago

Have a Great Weekend Y'all...🥳

👍️0

georgie18 3 weeks ago

TPST...$1.12s clearing here...🥳Reversing...

georgie18

Member Level
Re: georgie18 post# 662364

Friday, October 25, 2024 9:43:40 AM

Post#
662715
of 662771
TPST...$1.08...Big Block Buys hitting here...🥳

georgie18

Member Level
Re: None

Wednesday, October 23, 2024 8:55:30 AM

Post#
613
of 613
TPST...Loaded $1.03 to $1.05s...🥳

👍️0

georgie18 3 weeks ago

TPST...$1.08...Big Block Buys hitting here...🥳

georgie18

Member Level
Re: None

Wednesday, October 23, 2024 8:55:30 AM

Post#
613
of 613
TPST...Loaded $1.03 to $1.05s...🥳

👍️0

georgie18 3 weeks ago

TPST...Loaded $1.03 to $1.05s...🥳

👍️0

Xunefox 4 weeks ago

May be an AH show after all

👍️0

aBeezlee 4 weeks ago

Yup TPST! I have RNAZ on list too. Buying both with next check. 🔥

👍️0

georgie18 4 weeks ago

TPST...$1.22...🥳...Dipping it to fill the Open Gap...another great add spot...Ran to $1.60 range in the A/H ...

georgie18

Member Level
Re: georgie18 post# 384329

Tuesday, October 15, 2024 3:37:36 PM

Post#
384411
of 384426
TPST...$1.14clearing here...🥳

georgie18

Member Level
Re: None

Friday, October 11, 2024 9:46:27 AM

Post#
603
of 603
TPST...99...great add spot....🥳

👍️0

georgie18 4 weeks ago

TPST …yes beauty move in the A/H…🥳

👍️0

Vitamin310 4 weeks ago

I’m in!

👍️0

Money hunt 4 weeks ago

TPST smell green dude!!! RNAZ Next DRUG

👍️0

The GidDy uP Kid 1 month ago

Nice Georgie… TPST $1.61 after hours close…

georgie18 1 month ago

TPST...$1.14clearing here...🥳

georgie18

Member Level
Re: None

Friday, October 11, 2024 9:46:27 AM

Post#
603
of 603
TPST...99...great add spot....🥳

👍️0

georgie18 1 month ago

TPST...99...great add spot....🥳

👍️0

Invest-in-America 1 month ago

TPST: Nope!! Cancer is NOT trending anymore, CLOWN!!! (Nice call, IDIOT!!!)

👍️0

georgie18 1 month ago

TPST...$1.09...Great add opportunity...imo...we shall see...🥳

👍️0

georgie18 1 month ago

TPST...$1.59...from the .90 range bottom...🥳BRISBANE, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced an agreement with Roche to advance the evaluation of amezalpat (TPST-1120) in combination with atezolizumab (Tecentriq®) and bevacizumab, the current standard of care for unresectable or metastatic hepatocellular carcinoma (HCC), into a pivotal Phase 3 trial for the first-line treatment of unresectable or metastatic hepatocellular carcinoma, a form of liver cancer with high unmet need.

georgie18

Member Level
Re: None

Friday, August 09, 2024 2:43:01 PM

Post#
652989
of 660804
TPST...$1.16...Taking a hit on earnings...adding more down here...🥳

👍️0

TrendTrade2016 1 month ago

july shelf offering allows lender to sell stock at anytime

👍️0

Invest-in-America 1 month ago

TPST: Hopefully!! (But is "Cancer" TRENDING anymore??)

👍️0

tw0122 1 month ago

TPST 1.82 +’35% resistance at 1.85 looks good again until 2.01- 2.23 resistance then big jump to 2.91

a pivotal Phase 3 trial for the first-line treatment of unresectable or metastatic hepatocellular carcinoma, a form of liver cancer with high unmet need.
Under the agreement, Roche will supply atezolizumab globally and Tempest will sponsor and lead the pivotal study. This agreement builds on a clinical collaboration between the companies pursuant to which amezalpat was combined with atezolizumab and bevacizumab in first-line HCC patients and compared to atezolizumab and bevacizumab alone in a randomized Phase 1b/2 study. Tempest retains all development and commercial rights to amezalpat.

👍️0

Invest-in-America 1 month ago

TPST: I'm in!! Are you?? (Heck, goin' to Phase-3 with Roche?? I'll jump-on for ride!!)

👍️0

Invest-in-America 1 month ago

TPST: Some Roche agreement news.

👍️0

georgie18 2 months ago

TPST...$1.44s clearing on the 50MA Break...🥳

👍️0

georgie18 2 months ago

TPST...$1.50s clearing into the close...🥳

👍️0

georgie18 2 months ago

Have a Great Weekend Y'all...🥳

👍️0

georgie18 2 months ago

Nice...will be very pleased with 1/2 that target...🥳

👍️0

glens0 2 months ago

Bought a starter today.
DJ Tempest Therapeutics Price Target Maintained With a $47.00/Share by HC Wainwright & Co.
12:54 PM ET 8/15/24 | Dow Jones

👍️0

georgie18 2 months ago

TPST...$1.35...🥳

👍️0

georgie18 3 months ago

TPST...$1.44...HOD...🥳

👍️0

georgie18 3 months ago

TPST...$1.50...Off the .90 range dip...🥳...was $6 recently...setting up for a Breakout...imo...we shall see...

👍️0

georgie18 3 months ago

TPST...1.4995...HOD...Beauty move off the .90 range dip...🥳Was $6 a couple of months ago...🥳

👍️0

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Tempest Therpeutics Inc (TPST)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

TPST News

Form DEF 14A - Other definitive proxy statements

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update

Form 8-K - Current report

Tempest Receives FDA Study May Proceed for Pivotal Phase 3 Trial of Amezalpat Combination Therapy for the Treatment of First-Line Hepatocellular Carcinoma

Form PRE 14A - Other preliminary proxy statements

Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]

Form 8-K - Current report

Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial

Tempest Extends Limited Duration Stockholder Rights Plan

Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tempest Further Strengthens Leadership Team with Appointment of Sheldon Mullins as Vice President, Regulatory Affairs

Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance

TPST Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Tempest Therpeutics Inc (TPST) News

Tempest Therpeutics Inc (TPST)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

TPST News

Form DEF 14A - Other definitive proxy statements

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update

Form 8-K - Current report

Tempest Receives FDA Study May Proceed for Pivotal Phase 3 Trial of Amezalpat Combination Therapy for the Treatment of First-Line Hepatocellular Carcinoma

Form PRE 14A - Other preliminary proxy statements

Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]

Form 8-K - Current report

Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial

Tempest Extends Limited Duration Stockholder Rights Plan

Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tempest Further Strengthens Leadership Team with Appointment of Sheldon Mullins as Vice President, Regulatory Affairs

Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance

TPST Discussion

Your Recent History

Company

Business

Popular

Get The App